Skip to content

SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)

Predictive Outcome Model Over Time for Employment (PROMOTE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01141647
Acronym
PrOMOTE
Enrollment
1047
Registered
2010-06-10
Start date
2011-08-31
Completion date
2015-03-31
Last updated
2017-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Adult, Depression, Supported Employment, Health Service, Humans, Outcomes, Quality of Life, Veterans/rh (rehabilitation), Workplace, Spinal Cord Injuries

Brief summary

This study will be an extension of the Spinal Cord Injury Vocational Integration Program (SCI-VIP). The study involves research about how to help Veterans with spinal cord injury (SCI) gain employment. Vocational rehabilitation is a special field of service aimed at putting persons with disabilities in the best possible position to become employed. The Veterans Administration has a long history of providing vocational rehabilitation for Veterans with mental health issues and has recently started providing similar services to persons with physical disabilities, including SCI. Past research has shown that vocational rehabilitation is effective in helping some Veterans with spinal cord injury (SCI) gain employment. The extension of this work through PrOMOTE study will establish a large national database of over 2000 Veterans with SCI, containing extensive employment, medical, functional and psychosocial data. The study will analyze both quantitative and qualitative measures to maximize its findings.

Detailed description

Extending SCI-VIP through PrOMOTE will operationalize the critical features of supported employment that lead to obtaining and maintaining employment over time in spinal cord injury. There are no current studies that examine how the level and intensity of supported employment services by Veterans with SCI impacts employment outcomes. This extension will allow the examination of longitudinal factors associated with successful employment that are not possible within the time constrains of SCI-VIP and to extend the cost-effectiveness analysis and budget impact analysis to include longer term and costs of quality of life outcomes. The study will include a more comprehensive qualitative analysis across several sites of factors that contribute to program success. The PrOMOTE study will add three more sites. This expansion will allow examination of outcomes in areas where there is a high penetration of OIF/OEF Veterans as well as sites where there are other vocational programs available. Primary HO: Identify factors that predict employment after SCI. Secondary HO 1: Determine ongoing effectiveness of SE over time. Secondary HO 2: Evaluate the effectiveness of implementation strategy and level of SE model implementation across sites. Secondary HO 3: Determine costs, health care utilization over time and cost-effectiveness.

Interventions

SCI-VIP: PrOMOTE evidence-based supported employment implemented for Veterans with spinal cord injury or other available vocational services

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

All Veterans who meet inclusion criteria will be approached about completing a baseline interview to gather information on employment, health, and quality of life after spinal cord injury. Inclusion criteria for the baseline interview include: * 18 to 65 years old * Spinal Cord Injury * Medically and neurologically stable At the end of the baseline interview, some of these Veterans who meet additional inclusion criteria will be enrolled to receive the SE intervention or other available vocational services and complete longitudinal follow-up interviews every three months while participating in the study. The additional inclusion criteria for enrollment in vocational services include: * Unemployed * Living within 100 mile radius of the enrolling VA Medical Center * Desiring competitive employment A subsample of Veterans who consent to the study will be selected for participation in qualitative interviews. Family members and/or caregivers identified by these Veterans may also be included in qualitative interviews. A representative sample of VA staff members who provide care to these Veterans will also be approached to participate in qualitative interviews.

Exclusion criteria

* Medically and/or surgically unstable * Mentally impaired such that independent reasoning and judgment jeopardize safety of self or others * Active alcohol and/or drug dependency that is untreated

Design outcomes

Primary

MeasureTime frameDescription
Identify Factors That Predict Employment After SCI.24-month phase with face-to-face quarterly interviewsTo model the probability of obtaining CE, we first dichotomized CE as 'yes' or 'no'. The Competitive Employment Rate is reported in Outcome Measure 2. We then used unconditional logistic regression to model the probability of obtaining CE through a univariate modeling approach to determine statistically significant predictors of CE. Statistically significant predictors at the p\<0.10 criterion level were then explored in a final multivariate model. Demographic (age, race, marital status, etc.), clinical (severity of injury, comorbidities, time since injury, etc.), barriers and facilitators, and quality of life (depression, Satisfaction with Life, etc.) were considered for modeling. A final model was obtained by including all parameters meeting the p\<0.10 criterion into a final multivariate model.

Secondary

MeasureTime frameDescription
Employment Rate24 MonthsCompetitive Employment (CE) rate for individuals who participated in the Supported Employment arm of the PrOMOTE Study.
Determine Ongoing Effectiveness of SE Over Time.48-month phase with face-to-face quarterly interviewsThis measure is used to evaluate the participants who were both in SCI-VIP and PrOMOTE. It assesses the number of people who obtained CE in SCI-VIP and sustained the same CE through their time in the PrOMOTE study. The cohort of SCI-VIP SE participants in PrOMOTE were analyzed separately from the 213 PrOMOTE participants.
Evaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.24-month phase with face-to-face quarterly interviewsLevel of implementation was assessed by interviewing clinical and vocational providers from the seven sites who were involved in or knowledgeable about the program. Values reported represent the numbers of clinical staff who cited having the VRS integrated on the clinical team, a full-time VRS, leadership support, engagement of staff, resources provided immediately, making adjustments to the implementation to fit with the local context, and having audit and feedback as supporting strong implementation
Determine Total Cost Per Patient Over 24 Months24-month phase with face-to-face quarterly interviewsTotal cost is the mean total cost per patient over 24 months in US dollars. The minimum value is 0 representing no cost in US dollars and larger numbers indicating higher costs in US dollars.
Determine Cost-effectiveness.24-month phase with face-to-face quarterly interviewsQALYs are the mean quality adjusted life years per patient for the Supported Employment and Standard Care groups. The QALY is a non-negative number assessing the quality and length of life and not just the crude number of years. The minimum value is 0 representing no improvement in the quality of life or length of life and larger numbers indicate healthier and longer life. Maximum QALYs are limited only by the life span of study participants, but may not exceed 1 (perfect health) in any given year.

Countries

United States

Participant flow

Pre-assignment details

1047 subjects were enrolled; 450 were ineligible for supported employment (SE) services and 318 were out of the SE recruitment window. 279 SE participants remained, and 66 were analyzed separately because of their previous participation in SE. For the purposes of reporting 213 subjects were included

Participants by arm

ArmCount
24-Month Supported Employment
Evidence-Based Supported Employment Vocational Rehabilitation or Other Vocational Services Vocational Rehabilitation: SCI-VIP: PrOMOTE evidence-based supported employment implemented for Veterans with spinal cord injury or other available vocational services
1,047
Total1,047

Baseline characteristics

Characteristic24-Month Supported Employment
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
1047 Participants
Age, Continuous53.3 years
STANDARD_DEVIATION 10.1
AIS and neurological Level
AIS D/E
372 participants
AIS and neurological Level
High Tetraplegia, AIS, A, B, C
91 participants
AIS and neurological Level
Low Tetraplegia, AIS A,B,C
200 participants
AIS and neurological Level
Missing
13 participants
AIS and neurological Level
Paraplegia, AIS A,B,C
371 participants
ASIA Impairment Scale (AIS)
A
408 participants
ASIA Impairment Scale (AIS)
B
121 participants
ASIA Impairment Scale (AIS)
C
133 participants
ASIA Impairment Scale (AIS)
D
366 participants
ASIA Impairment Scale (AIS)
E
7 participants
ASIA Impairment Scale (AIS)
Missing
12 participants
Education Years13.8 years
STANDARD_DEVIATION 2.4
Functional Independence Measure71.5 units on a scale
STANDARD_DEVIATION 27.2
Marital Status
Divorced
366 participants
Marital Status
Married
373 participants
Marital Status
Other
305 participants
Marital Status
Refused/NA
3 participants
Measures of Handicap (CHART)
Cognitive
90.7 units on a scale
STANDARD_DEVIATION 16.2
Measures of Handicap (CHART)
Economic Self Sufficiency
57.9 units on a scale
STANDARD_DEVIATION 42.1
Measures of Handicap (CHART)
Mobility
76.8 units on a scale
STANDARD_DEVIATION 23.9
Measures of Handicap (CHART)
Occupation
47.6 units on a scale
STANDARD_DEVIATION 33.9
Measures of Handicap (CHART)
Physical
85.4 units on a scale
STANDARD_DEVIATION 20.9
Measures of Handicap (CHART)
Social Integration
88.6 units on a scale
STANDARD_DEVIATION 14.5
Military Service-connected 100%
Missing
69 participants
Military Service-connected 100%
N/A
379 participants
Military Service-connected 100%
No
258 participants
Military Service-connected 100%
Yes
341 participants
Military Service-connected benefits for SCI
Missing/Other
35 participants
Military Service-connected benefits for SCI
N/A
444 participants
Military Service-connected benefits for SCI
No
237 participants
Military Service-connected benefits for SCI
Yes
331 participants
Monthly Non-Service-connected pension1078 Dollars
STANDARD_DEVIATION 795.4
Monthly Social Security Disability Insurance Benefits1215 Dollar
STANDARD_DEVIATION 556.2
Monthly Social Security Income Benefits994 Dollars
STANDARD_DEVIATION 485.2
Neither Social Security Income/Social Security Disability Insurance Recipient
Missing/Other
13 participants
Neither Social Security Income/Social Security Disability Insurance Recipient
N/A
2 participants
Neither Social Security Income/Social Security Disability Insurance Recipient
Neither
234 participants
Neither Social Security Income/Social Security Disability Insurance Recipient
One or more
798 participants
Non-Service-connected pension
Missing/Other
39 participants
Non-Service-connected pension
N/A
378 participants
Non-Service-connected pension
No
498 participants
Non-Service-connected pension
Yes
132 participants
Quality of Life VR-36
Mental Component Scale
56.5 T-score
STANDARD_DEVIATION 12.4
Quality of Life VR-36
Physical Component Scale
27.2 T-score
STANDARD_DEVIATION 8.6
Race/Ethnicity, Customized
African American
306 participants
Race/Ethnicity, Customized
Asian
13 participants
Race/Ethnicity, Customized
Caucasion
653 participants
Race/Ethnicity, Customized
Native American
15 participants
Race/Ethnicity, Customized
Other/Unknown
60 participants
Sex: Female, Male
Female
45 Participants
Sex: Female, Male
Male
1002 Participants
VA Benefits Recipient
Missing/Other
21 participants
VA Benefits Recipient
N/A
2 participants
VA Benefits Recipient
No
369 participants
VA Benefits Recipient
Yes
655 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
21 / 1,047
serious
Total, serious adverse events
150 / 1,047

Outcome results

Primary

Identify Factors That Predict Employment After SCI.

To model the probability of obtaining CE, we first dichotomized CE as 'yes' or 'no'. The Competitive Employment Rate is reported in Outcome Measure 2. We then used unconditional logistic regression to model the probability of obtaining CE through a univariate modeling approach to determine statistically significant predictors of CE. Statistically significant predictors at the p\<0.10 criterion level were then explored in a final multivariate model. Demographic (age, race, marital status, etc.), clinical (severity of injury, comorbidities, time since injury, etc.), barriers and facilitators, and quality of life (depression, Satisfaction with Life, etc.) were considered for modeling. A final model was obtained by including all parameters meeting the p\<0.10 criterion into a final multivariate model.

Time frame: 24-month phase with face-to-face quarterly interviews

ArmMeasureValue (NUMBER)
24-Month Supported EmploymentIdentify Factors That Predict Employment After SCI.3.56 Odds Ratio
90% CI: [1.8, 7.07]
Secondary

Determine Cost-effectiveness.

QALYs are the mean quality adjusted life years per patient for the Supported Employment and Standard Care groups. The QALY is a non-negative number assessing the quality and length of life and not just the crude number of years. The minimum value is 0 representing no improvement in the quality of life or length of life and larger numbers indicate healthier and longer life. Maximum QALYs are limited only by the life span of study participants, but may not exceed 1 (perfect health) in any given year.

Time frame: 24-month phase with face-to-face quarterly interviews

Population: 213 SE participants in the PrOMOTE study were compared to 76 individuals in the control group of the SCI-VIP study.

ArmMeasureValue (MEAN)Dispersion
24-Month Supported EmploymentDetermine Cost-effectiveness.1.27 yearsStandard Deviation 0.068
Mid StageDetermine Cost-effectiveness.1.15 yearsStandard Deviation 0.058
Secondary

Determine Ongoing Effectiveness of SE Over Time.

This measure is used to evaluate the participants who were both in SCI-VIP and PrOMOTE. It assesses the number of people who obtained CE in SCI-VIP and sustained the same CE through their time in the PrOMOTE study. The cohort of SCI-VIP SE participants in PrOMOTE were analyzed separately from the 213 PrOMOTE participants.

Time frame: 48-month phase with face-to-face quarterly interviews

Population: Number of participants in 24-month SE and 24-month SCI-VIP (previous study).

ArmMeasureValue (NUMBER)
24-Month Supported EmploymentDetermine Ongoing Effectiveness of SE Over Time.5 participants
Secondary

Determine Total Cost Per Patient Over 24 Months

Total cost is the mean total cost per patient over 24 months in US dollars. The minimum value is 0 representing no cost in US dollars and larger numbers indicating higher costs in US dollars.

Time frame: 24-month phase with face-to-face quarterly interviews

Population: 213 SE participants in the PrOMOTE study were compared to 76 individuals in the control group of the SCI-VIP study.

ArmMeasureValue (MEAN)
24-Month Supported EmploymentDetermine Total Cost Per Patient Over 24 Months134,029 US dollars
Mid StageDetermine Total Cost Per Patient Over 24 Months169,433 US dollars
Secondary

Employment Rate

Competitive Employment (CE) rate for individuals who participated in the Supported Employment arm of the PrOMOTE Study.

Time frame: 24 Months

ArmMeasureValue (NUMBER)
24-Month Supported EmploymentEmployment Rate43.2 percentage of participants with CE
Secondary

Evaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.

Level of implementation was assessed by interviewing clinical and vocational providers from the seven sites who were involved in or knowledgeable about the program. Values reported represent the numbers of clinical staff who cited having the VRS integrated on the clinical team, a full-time VRS, leadership support, engagement of staff, resources provided immediately, making adjustments to the implementation to fit with the local context, and having audit and feedback as supporting strong implementation

Time frame: 24-month phase with face-to-face quarterly interviews

Population: Each stage comprised of two site visits. Please note that in the early stage fit of IPS model and audit and feedback were not assessed in either of the site visits, hence a value of zero is entered. Also note that in the late stage obtaining resources, fit of IPS model, and audit and feedback were only assessed at 1/2 of the site visits.

ArmMeasureGroupValue (NUMBER)
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.VRS20 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Obtaining resources10 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Engagement of staff21 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Integration of vocational and clinical team32 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Audit and Feedback0 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Fit of IPS Model0 participants
24-Month Supported EmploymentEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Leadership Support17 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Engagement of staff9 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Integration of vocational and clinical team30 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.VRS14 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Leadership Support17 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Obtaining resources9 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Fit of IPS Model13 participants
Mid StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Audit and Feedback0 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Obtaining resources6 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.VRS19 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Audit and Feedback7 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Fit of IPS Model4 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Engagement of staff13 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Leadership Support13 participants
Late StageEvaluate the Effectiveness of Implementation Strategy and Level of SE Model Implementation Across Sites.Integration of vocational and clinical team30 participants

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026